04/03/2025
3:27 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
7:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
9:46 AM | Aptose Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2025
7:42 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
5:48 PM | Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
| Form SCHEDULE 13G/A | |
03/24/2025
4:02 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
6:14 PM | Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
| Form SCHEDULE 13G/A | |
03/20/2025
7:54 PM | Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
03/20/2025
7:54 PM | Aptose Biosciences (Issuer)
Hanmi Pharmaceutical Co., Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/17/2025
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:12 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for APTO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
02/20/2025
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
7:26 PM | Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
| Form SCHEDULE 13G | |
02/13/2025
4:30 PM | Aptose Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
02/13/2025
4:14 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:42 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
6:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:41 PM | Aptose Biosciences (Filer)
| Form 424B5 | |
01/28/2025
3:31 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
4:21 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:01 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
6:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
5:57 PM | Aptose Biosciences (Filer)
| Form DEF 14A | |
12/27/2024
5:59 PM | Aptose Biosciences (Filer)
| Form DEFA14A | |
12/19/2024
3:10 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:03 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
12/12/2024
9:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
11:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:56 PM | Aptose Biosciences (Issuer)
Rice William G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:27 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
5:05 AM | Aptose Biosciences (Filer)
| Form 424B4 | |
11/22/2024
7:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
11:15 PM | Aptose Biosciences (Filer)
| Form EFFECT | |
11/20/2024
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
2:22 PM | Aptose Biosciences (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
10/31/2024
5:39 AM | Aptose Biosciences (Filer)
| Form S-1/A | |
10/04/2024
3:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad) Did Elon Musk just set the stage for the next AI stock explosion?
One 30-year Wall Street veteran thinks so.
Musk has been quietly creating one of the most ambitious AI ventures in history. For all the details - including the name and ticker of our #1 AI stock to buy right now - click here |
08/15/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:22 PM | Aptose Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
8:43 PM | Aptose Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/26/2024
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:00 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
10:43 AM | Aptose Biosciences (Filer)
| Form DEF 14A | |
07/05/2024
9:19 AM | Aptose Biosciences (Filer)
| Form PRE 14A | |
06/14/2024
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
9:32 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Aptose Biosciences (Filer)
| Form 424B5 | |
05/31/2024
7:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
10:47 AM | Aptose Biosciences (Filer)
| Form DEF 14A | |
05/10/2024
10:35 AM | Aptose Biosciences (Issuer)
LEDRU PHILIPPE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:21 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
04/29/2024
4:19 PM | Aptose Biosciences (Filer)
| Form 10-K/A | |
04/26/2024
11:54 AM | Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
| Form SC 13D/A | |
04/26/2024
6:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy APTO Stock Free APTO Stock Alerts